5 research outputs found

    E-waste Management-Suggested Solutions

    Full text link
    Electronic waste has been identified as discarded computers, old television sets, electronic equipment, entertainment devices, mobile phones, and refrigerators. This definition mostly include used electronics. Because loads of surplus electronics are frequently not eliminated including goods, recyclable, and non-recyclable so several people apply the term "e-waste" broadly to all surplus electronics. Rapid changes in technology, changes in media, falling prices, and planned obsolescence have resulted in a fast-growing surplus of electronic waste around the globe. This paper has an objective to present an overview of the problem and tries to advocate some concrete solutions to tackle the issue

    Vitamin E succinate inhibits survivin and induces apoptosis in pancreatic cancer cells

    No full text
    Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States. Identifying novel chemotherapeutic and chemopreventive approaches is critical in the prevention and treatment of cancers such as pancreatic cancer. Vitamin E succinate (VES) is a redox-silent analog of the fat-soluble vitamin alpha-tocopherol. In the present study, we explored the antiproliferative action of VES and its effects on inhibitor of apoptosis proteins in pancreatic cancer cells. We show that VES inhibits cell proliferation and induces apoptosis in pancreatic cancer cells. Further, we demonstrate that VES downregulates the expression of survivin and X-linked inhibitor of apoptosis proteins. The apoptosis induced by VES was augmented by siRNA-mediated inhibition of survivin in PANC-1 cells. In summary, our results suggest that VES targets survivin signaling and induces apoptosis in pancreatic cancer cells

    Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

    No full text
    BACKGROUND: Many patients with atrial fibrillation have concomitant coronary artery disease with or without acute coronary syndromes and are in need of additional antithrombotic therapy. There are few data on the long-term clinical outcome of atrial fibrillation patients with a history of acute coronary syndrome. This is a 2-year study of atrial fibrillation patients with or without a history of acute coronary syndromes
    corecore